PL2162143T3 - Mikroorganizmy mleka ssaków, kompozycje je zawierające i ich zastosowanie w leczeniu zapalenia sutka - Google Patents

Mikroorganizmy mleka ssaków, kompozycje je zawierające i ich zastosowanie w leczeniu zapalenia sutka

Info

Publication number
PL2162143T3
PL2162143T3 PL08760355T PL08760355T PL2162143T3 PL 2162143 T3 PL2162143 T3 PL 2162143T3 PL 08760355 T PL08760355 T PL 08760355T PL 08760355 T PL08760355 T PL 08760355T PL 2162143 T3 PL2162143 T3 PL 2162143T3
Authority
PL
Poland
Prior art keywords
mastitis
treatment
compositions containing
mammalian milk
microorganisms
Prior art date
Application number
PL08760355T
Other languages
English (en)
Inventor
Jiménez Rocío Martín
Martín Mónica Olivares
Quintana Esther Antonia Jiménez
Martínez María Luisa Marín
Ávila Saleta Sierra
Barragán Antonio Maldonado
Merino Virginia Martín
Martell Francesc Blanch
Lloveras Celina Torre
Villoslada Federico Lara
Rodríguez Rebeca Arroyo
Puerta Julio Boza
López Jesús Jiménez
Álvarez Leónides Fernández
Abuja Odón Julián Sobrino
Pei Jordi Xaus
Gómez Juan Miguel Rodríguez
Palacio Susana Delgado
Original Assignee
Biosearch S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch S A filed Critical Biosearch S A
Publication of PL2162143T3 publication Critical patent/PL2162143T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
PL08760355T 2007-05-31 2008-06-02 Mikroorganizmy mleka ssaków, kompozycje je zawierające i ich zastosowanie w leczeniu zapalenia sutka PL2162143T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07380158A EP1997499A1 (en) 2007-05-31 2007-05-31 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP08760355.1A EP2162143B1 (en) 2007-05-31 2008-06-02 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
PCT/EP2008/056768 WO2008145756A1 (en) 2007-05-31 2008-06-02 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis

Publications (1)

Publication Number Publication Date
PL2162143T3 true PL2162143T3 (pl) 2016-03-31

Family

ID=38657070

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08760355T PL2162143T3 (pl) 2007-05-31 2008-06-02 Mikroorganizmy mleka ssaków, kompozycje je zawierające i ich zastosowanie w leczeniu zapalenia sutka

Country Status (16)

Country Link
US (1) US8557560B2 (pl)
EP (2) EP1997499A1 (pl)
JP (1) JP5710250B2 (pl)
AU (1) AU2008257455B2 (pl)
CA (1) CA2689360C (pl)
CO (1) CO6270334A2 (pl)
DK (1) DK2162143T3 (pl)
ES (1) ES2555159T3 (pl)
HU (1) HUE025851T2 (pl)
IL (1) IL202386A0 (pl)
MX (1) MX2009013044A (pl)
NZ (1) NZ581576A (pl)
PL (1) PL2162143T3 (pl)
PT (1) PT2162143E (pl)
RU (1) RU2446814C2 (pl)
WO (1) WO2008145756A1 (pl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
RU2476591C1 (ru) * 2011-08-19 2013-02-27 Федеральное государственное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для приготовления кисломолочных продуктов
RU2477313C1 (ru) * 2011-08-25 2013-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ Enterococcus hirae, ИСПОЛЬЗУЕМЫЙ ПРИ ПРОИЗВОДСТВЕ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ
RU2476592C1 (ru) * 2011-09-02 2013-02-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для производства кисломолочных продуктов
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CA3107450A1 (en) 2012-03-29 2013-10-03 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN105517557B (zh) 2013-04-23 2021-11-30 特雷根控股有限公司 具有抗微生物活性的细菌菌株以及包含所述菌株的生物控制组合物
DE102013105666A1 (de) * 2013-06-03 2014-12-04 Hochschule Hannover Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel
EP2818056A1 (en) 2013-06-25 2014-12-31 Biosearch S.A. Probiotic bacteria comprising metals, metal nanoparticles and uses thereof
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
ES2615808T3 (es) 2013-10-16 2017-06-08 Casen Recordati, S.L. Microorganismos y composiciones que los comprenden para su uso en el tratamiento o prevención de mastitis
WO2015093937A1 (en) * 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
RU2741836C2 (ru) * 2014-10-21 2021-01-29 Акилон Киль Сосьедад Лимитада Композиции пробиотиков и пребиотиков
BR112017013274A2 (pt) 2014-12-23 2018-02-06 4D Pharma Research Limited polipeptídeo e imunomodulação
SG11201704811YA (en) 2014-12-23 2017-07-28 4D Pharma Res Ltd Immune modulation
AU2016208009A1 (en) * 2015-01-16 2017-07-20 Biogaia Ab Lactic Acid Bacteria and their use for the treatment of mastitis
EP3250217A1 (en) * 2015-01-30 2017-12-06 Technische Universität München Composition for use in preventing and/or treating diarrhea in animals
EP3277255A1 (en) 2015-03-31 2018-02-07 GOJO Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN115364122A (zh) 2015-06-15 2022-11-22 4D制药研究有限公司 包含细菌菌株的组合物
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SI3307288T1 (sl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Spojine, ki vsebujejo bakterijske seve
SK542015A3 (sk) * 2015-07-30 2017-02-02 Univerzita Pavla Jozefa Šafárika V Košiciach Kmene mikroorganizmov Lactobacillus Plantarum LS/07 CCM 7766 a spôsob ich využitia
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN112569262A (zh) 2015-11-20 2021-03-30 4D制药研究有限公司 包含细菌菌株的组合物
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
JP7121996B2 (ja) * 2015-12-24 2022-08-19 デイリー ア デイ インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓ ｆｅｒｍｅｎｔｕｍの新規株の組成物および使用の方法
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN108883139B (zh) 2016-03-04 2022-04-26 4D制药有限公司 包含细菌菌株的组合物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
JP6986288B2 (ja) * 2017-01-13 2021-12-22 ベネド バイオメディカル カンパニー リミテッド 新規乳酸菌およびその応用
MA48939B1 (fr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
JP6837581B2 (ja) 2017-06-14 2021-03-03 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ Ｍｅｇａｓｐｈａｅｒａ属の細菌株を含む組成物及びその使用
RS61210B1 (sr) 2017-06-14 2021-01-29 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
AU2019237674B2 (en) * 2018-03-23 2023-06-08 Morinaga Milk Industry Co., Ltd. Composition for enhancing breast milk component
US20220184153A1 (en) * 2019-03-25 2022-06-16 The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO Method of treating bovine mastitis
EP3996510A4 (en) * 2019-07-08 2023-08-09 BioPlx, Inc. LIVING BIOTHERAPEUTIC COMPOSITIONS AND PROCESSES
WO2021105353A1 (en) * 2019-11-29 2021-06-03 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
CN117338823A (zh) * 2023-12-06 2024-01-05 山东百德生物科技有限公司 一种动物酵素发酵液及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591499A (en) 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis
DK0577904T3 (da) * 1992-07-06 1997-10-27 Nestle Sa Mælkesyrebakterie.
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
IE20030773A1 (en) * 2003-10-17 2005-04-20 Teagasc Agric Food Dev Authori Use of probiotic bacteria in the treatment of infection
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy

Also Published As

Publication number Publication date
NZ581576A (en) 2012-01-12
ES2555159T3 (es) 2015-12-29
AU2008257455A1 (en) 2008-12-04
EP2162143A1 (en) 2010-03-17
RU2446814C2 (ru) 2012-04-10
JP2010528093A (ja) 2010-08-19
JP5710250B2 (ja) 2015-04-30
US8557560B2 (en) 2013-10-15
CA2689360C (en) 2017-03-14
AU2008257455B2 (en) 2014-05-01
MX2009013044A (es) 2010-04-12
BRPI0811973A2 (pt) 2014-10-21
EP2162143B1 (en) 2015-09-09
HUE025851T2 (en) 2016-04-28
CO6270334A2 (es) 2011-04-20
US20100266550A1 (en) 2010-10-21
EP1997499A1 (en) 2008-12-03
RU2009149393A (ru) 2011-07-10
CA2689360A1 (en) 2008-12-04
IL202386A0 (en) 2010-06-30
DK2162143T3 (en) 2015-12-14
WO2008145756A1 (en) 2008-12-04
PT2162143E (pt) 2016-01-07

Similar Documents

Publication Publication Date Title
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
IL261338B (en) Preparations and methods for the treatment of wide-ranging, undifferentiated or mixed clinical applications
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
EP2536406A4 (en) BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, COMPRISING THE TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
EP2593187A4 (en) METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH
EP2323677A4 (en) MICRO-RNA BASED COMPOSITIONS AND METHODS OF DIAGNOSIS, FORECAST AND TREATMENT OF MULTIPLE MYELOMA
IL202379A (en) Benzoxaborols, their pharmaceutical preparations and their use in the preparation of bacteria to inhibit the growth of germs
EP2066785A4 (en) BACTERIAL CULTURES AND COMPOSITIONS WITH BACTERIAL CULTURES
EP2212440A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES
EP2046352A4 (en) FERMENTED MILK PRODUCT AND ITS USE
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
WO2010062863A3 (en) Compositions containing satiogens and methods of use
ZA201003978B (en) Composition for human and/or animal nutrition, uses thereof and yeasts
ZA201000491B (en) New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP2112219A4 (en) NEW LACTIC ACID BACTERIA
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
IL209360A (en) Medications containing pm00104 for the treatment of multiple myeloma
PL2591102T3 (pl) Procedura specyficznej izolacji całkowitej zawartości dna drobnoustrojów bakteryjnych i zestaw do tego celu
EP2583969A4 (en) NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS
IN2012DN03404A (pl)
IL218388A (en) Hydroxyphenyl compounds, pharmaceuticals containing them, their use in the treatment of antimicrobial infections, their preparation and intermediates in the process
PL1998747T3 (pl) Zastosowanie fermentowanego produktu mlecznego do pielęgnacji skóry
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS